Table 2 Comparison between the PHARE-M Group and the paired Control Group
From: Quality of care in cystic fibrosis: assessment protocol of the French QIP PHARE-M
Comparison between PHARE-M Group and Control Group | PIIARE-M (N = l104) | Controles (N = 1104) | Patients PHARE non paired (N = 205) | Comparison between PIIARE-M Group and Control Group (proc TTEST) | |
|---|---|---|---|---|---|
Gender | Men n (%) | 582 (52.72) | 564 (51.09) | 93 (45.37) | |
Female n (%) | 522 (47.28) | 540 (48.91) | 112 (54.63) | ||
Age | Average | 15.57 | 16.05 | 14.48 | |
Std Deviation | 10.73 | 11.00 | 10.51 | ||
Age (classes) | 0-04 n (%) | 182 (16.49) | 175 (15.85) | 32 (15.611) | |
05-09 n (%) | 209 (18.93) | 206 (18.66) | 42 (20.49) | ||
10-14 n (%) | 213 (19.29) | 204 (18.48) | 48 (23.41) | ||
15-19 n (%) | 169 (15.31) | 168 (15.22) | 38 (18.54) | ||
20-24 n (%) | 125 (11.32) | 130 (11.78) | 19 (927) | ||
25-29 n (%) | 93 (8.42) | 84 (7.61) | 10 (4.88) | ||
30-34 n (%) | 53 (4.80) | 68 (6.16) | 4 (1.95) | ||
35-39 n (%) | 36 (3.26) | 34 (3.08) | 6 (2.93) | ||
40-44 n (%) | 7 (0.63) | 18 (1.63) | 1 (0.49) | ||
45-49 n (%) | 9 (0.82) | 11 (1.00) | 4 (1.95) | ||
50-54 n (%) | 4 (0.36) | 3 (0.27) | 0 | ||
55-59 n (%) | 4 (0.36) | 2 (0.18) | 0 | ||
60-64 n (%) | 0 | 0 | 1 (0.49) | ||
70-74 n (%) | 0 | 1 (0.09) | 0 | ||
VEMS | Nmtss | 223 | 270 | 49 | (p = 0.0012 IS) |
Average | 83.00 | 79.11 | 85 06 | ||
Std Deviation | 23.96 | 25.81 | 21.92 | ||
ZBMI | Nmiss | 7 | 39 | 2 | p = 0.5171 (NS>) |
Average | -0.17 | -0.14 | -0.18 | ||
Std Deviation | 1.05 | 1.15 | 1.11 | ||